Tilley Jenkins Vogel
Papers
1
Total Citations
45
H-Index
1
About
Dr. Tilley Jenkins Vogel is a gynecologic oncologist whose research focuses on improving outcomes for patients with aggressive, high-risk endometrial cancers. Her most cited work, a 2015 analysis of treatment practices for uterine papillary serous carcinoma (UPSC) and uterine clear cell carcinoma (UCCC) at two high-volume cancer centers, has garnered 45 citations. This study addressed a critical gap in knowledge, as these rare subtypes contribute disproportionately to endometrial cancer deaths despite limited clinical data. By evaluating real-world treatment patterns, Dr. Vogel’s research provides valuable insights into optimizing therapeutic strategies for these challenging malignancies. Her work underscores the importance of evidence-based approaches to managing rare gynecologic cancers, directly informing clinical decision-making at major institutions. Through her contributions, Dr. Vogel has advanced the understanding of how to best treat these aggressive tumors, ultimately aiming to improve survival and quality of life for affected patients. Her dedication to addressing unmet needs in gynecologic oncology makes her a respected voice in the field.
Research Focus
Key Achievements
Top Papers
- 1